Skip to main content


Related Lawyers: Steve Rotman, Richard S. Lewis
Related Practice Areas: Mass Torts and Public Health Threats

Hausfeld has filed and is helping to lead lawsuits on behalf of mothers who were prescribed the anti-nausea medication Zofran (ondansetron) during their first trimester of pregnancy and who delivered children who suffered birth defects.

Zofran often was prescribed for morning sickness and hyperemesis gravidarum, a serious type of morning sickness that can cause severe weight loss.  Zofran was marketed and prescribed for morning sickness despite not being tested or approved for use by pregnant women.  Recent studies now show that mothers who took Zofran during their pregnancy (particularly in their first trimester) were at a significantly higher risk for delivering children with birth defects, including heart and craniofacial defects (including cleft palate and lip).

In 2012, GlaxoSmithKline, the manufacturer Zofran, agreed to a $3 Billion settlement with the Federal Government to resolve claims that it illegally marketed multiple medications (including Zofran) for off-label label uses.  Multiple lawsuits already have been filed against GlaxoSmithKline alleging that Zofran caused birth defects.

Steve Rotman of Hausfeld serves on the court-appointed Plaintiff Steering Committee in the In re Zofran Products Liability Litigation (MDL No. 2657) before the Honorable Judge F. Dennis Saylor IV of the United States District Court for the District of Massachusetts. He is co-chair of the science and expert committee. Hausfeld Partner James Gotz also serves as Plaintiff Co-Liaison Counsel for the MDL.


If you feel that Zofran may be the reason you or a loved one delivered a child with a birth defect, you need an attorney and an independent medical expert to review your case.

Supporting Documents

Related Lawyers